Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-04-23 È 22:08
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 19°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Cover Story]
Á¤½Å°Ç°Áúȯ ¡®Ãʱâ°ü¸®¡¯¿¡¼ ¹æÇâ Àâ´Â´Ù
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 18:17
[Sub Story]
[Çѱ¹Çü ¿ì¿ïÀå¾Ö ¾à¹°Ä¡·á Áöħ¼ 2021]
1´Ü°èºÎÅÍ ºñÁ¤Çü Ç×Á¤½Åº´¾à¹° °í·Á
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 18:12
[Sub Story]
[NICE ¼ºÀÎ ¿ì¿ïÁõ Ä¡·á¡¤°ü¸® °¡À̵å¶óÀÎ]
¾à¹°¿ä¹ý°ú ºñ¾à¹°¿ä¹ýÀÇ ÀûÀýÇÑ »ç¿ë °Á¶
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 18:04
[Sub Story]
º¸¸£Æ¼¿Á¼¼Æ¾ MDD ¡®¸ÂÃãÄ¡·á¡¯ ±Ù°Å ´õÇß´Ù
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 17:49
[Sub Story]
[Çѱ¹Çü ¾ç±Ø¼ºÀå¾Ö ¾à¹°Ä¡·á Áöħ¼ 2022]
±âºÐÁ¶ÀýÁ¦ + ºñÁ¤Çü Ç×Á¤½Åº´¾à¹° ¼±È£µµ È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 17:38
¶óÀÎ
[Sub Story]
[CANMAT ¾ç±Ø¼ºÀå¾Ö °ü¸® °¡À̵å¶óÀÎ 2018]
¾ç±Ø¼ºÀå¾Ö 1Çü ÃʱâºÎÅÍ º´¿ëµµ °í·Á °¡´É
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 17:08
[Interview]
¡°¿Ã¶õÀÚÇÉ, ´Ù¾çÇÑ ¾ç»ó º¸ÀÌ´Â ¾ç±Ø¼ºÀå¾Ö ¸ÂÃãÄ¡·á¿¡ È¿°úÀû ¿É¼Ç¡±
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 16:38
[Sub Story]
[Çѱ¹Çü Á¶Çöº´ ¾à¹°Ä¡·á Áöħ¼ 2019]
À¯¿¬ÇÑ Ä¡·á´Ü°è¡¤º´¿ë¿ä¹ý Àû¿ë ÁÖ¹®
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 16:34
[Interview]
¡°Á¶Çöº´µµ Á¶±âÁø´Ü ¡¤Á¶±âÄ¡·á ½Ã´ë·Î Á¢¾îµç´Ù¡±
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 16:29
[Sub Story]
[Ä¡¸Å ÀÓ»ó Áø·áÁöħ(Áø´Ü ¹× Æò°¡): °³Á¤¾È 2021]
¡°1Â÷Áø·áÀǵµ »ç¿ëÇÒ ¼ö À־
ÀÌ»óµ· ±âÀÚ
2022-09-05 16:16
¶óÀÎ
[Sub Story]
[WHO Global Action Plan to Dementia 2017-2025]
Ä¡¸Å À§Çè°¨¼Ò, »ýÈ°½À°ü°³¼±ºÎÅÍ
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 15:51
[Sub Story]
[À¯·´½Å°æ°úÇÐȸ Ä¡¸Å °ü¸®À̽´ °¡À̵å¶óÀÎ 2022]
Ä¡¸Å¿¹¹æ¿¡ Ç÷°ü¼º À§ÇèÀÎÀÚ ÁÖ¸ñ
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 15:43
[Drug Review]
µµ³×¸®¿ÂÆÐÃë, °æ±¸ ´ëºñ È¿°ú´Â µ¿µî
ÆíÀǼº°ú º¹¾à¼øÀÀµµ °³¼± ±â´ë
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 15:36
[Interview]
¡°º¹¾à¼øÀÀµµ °³¼±ÇÑ µµ³×ÆäÁú ÆÐÃëÁ¦Çü¡±
ÀÓ¼¼Çü ±âÀÚ
2022-09-05 15:23
[Interview]
¡°ÃÊÄ¡·á¿¡ À§»ê ¿¬°ü¼º °¨º°·Î ¿µÁ¡Àâ°í
ÀÌÈÄ Áõ»ó ¼ö½Ã¡¤½Å¼ÓÁ¶Àý ¾àÁ¦·Î ¸íÁß½ÃÄѾߡ±
ÀÌ»óµ· ±âÀÚ
2022-09-05 15:15
¶óÀÎ
[Conference Report]
Ç×°íÇ÷¾ÐÁ¦ º¹¿ë½Ã°£°ú ½ÉÇ÷°üÁúȯ ¿¹¹æÈ¿°ú ¿¬°ü¼ºÀº?
THE MOST
2022-09-05 15:10
[Conference Report]
SGLT-2¾ïÁ¦Á¦, ½ÉºÎÀü Àü¹Ý¿¡ ÇýÅÃ
THE MOST
2022-09-05 15:06
[Primary Expert Opinion]
¡®¸¸¼ºÁúȯ°ü¸®Á¦µµÀÇ ÇýÅðú °úÁ¦¡¯ Á´ãȸ
THE MOST
2022-09-05 15:03
[Cover Story]
[ESC 2022]
Àü¼¼°è¿¡ ±¹»ê ARBÇ÷¾Ð°ÇÏ¡¤½ÅÀ庸ȣȿ°ú ŸÀü
ÀÌ»óµ·
2022-09-02 10:46
-
1
-
¿©¹é
Sub
news
¡°Á¹·¹µå·Î³×ÀÌÆ® °ñÀý¿¹¹æ ÀÓ»ó±Ù°Å¡¤ÀûÀÀÁõ ÃÖ´Ù¡±
Q. °ñÀý¿¹¹æÀ» À§ÇÑ ¾à¹°Ä¡·á´Â ¾î¶»°Ô ±Ç°í...
¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡±
Q. ´ç´¢º´ Ä¡·á½Ã CGM ÀÓ»óÀû ¿ªÇÒÀº?ÀÓ...
¡°·Î¼ö¹Ù½ºÅ¸Æ¾ 20³â ±Ù°Å·Î ¼öÆÛ½ºÅ¸Æ¾ ¸í¼º À¯ÁöÇÒ °Í¡±
Q. ´ç´¢º´ ȯÀÚ¿¡¼ ÁöÁúÄ¡·á°¡ ÇÊ¿äÇÑ ÀÌÀ¯...
¿©¹é
¿©¹é
Back to Top